We have observed
2 EP applications
Julia Ann Venner
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after
January 16, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
RADIOLABELLED OCTREOTATE ANALOGUES AS PET TRACERS
HUMANIZED ANTIBODIES THAT SEQUESTER AMYLOID BETA PEPTIDE